BioSpace News Archive

Genetown

Bicycle Therapeutics to Present New Translational Data for BT1718 and Preclinical Data for Other Bicycle® Toxin Conjugates at AACR-NCI-EORTC 2019

New translational data will be presented for BT1718, the Company’s lead Bicycle® Toxin Conjugate (BTC) product candidate, which define enrollment criteria for identifying expansion cohorts in the Phase IIa part of the ongoing Phase I/IIa trial with BT1718.

October 16, 2019
·
8 min read
Deals

Avidity Science Acquires Edstrom Japan Ltd

Avidity Science is pleased to announce it has completed its acquisition of Edstrom Japan Ltd.

October 16, 2019
·
1 min read
Deals

Natera Announces Pricing of Follow-On Offering - Oct. 16, 2019

Natera, Inc., a global leader in cell-free DNA testing, announced the pricing of its underwritten public offering of 5,714,286 shares of its common stock at a price to the public of $35.00 per share.

October 16, 2019
·
2 min read
Myeloma Canada Launches Award-Winning Myeloma Monitor for Shared Decision-Making

Application Empowers Patients in Managing and Taking Control of their Disease

October 16, 2019
·
5 min read
Business

Turning Point Appoints Industry Veteran Nicole Hubach as Vice President Pharmaceutical Relations

Turning Point, an innovative specialty pharmacy network comprised of top performing specialty pharmacies, is pleased to announce Nicole Hubach, RPh, has joined the organization as the Vice President of Pharmaceutical Relations.

October 16, 2019
·
2 min read
Pharm Country

American Skin Association Announces Renewal Of SPOTS Education Outreach Grant

SPOTS program has increased its outreach to schools in the St. Louis area, created a seamless onboarding process for participants, and developed a new website.

October 16, 2019
·
2 min read
Business

Announcement of New President and Chief Executive Officer for Ag-West Bio

The Board of Directors of Ag-West Bio Inc. is pleased to announce the appointment of Karen Churchill as the organization’s next president and chief executive officer.

October 16, 2019
·
2 min read
Business

Amedisys Announces Third Quarter Earnings Release and Conference Call Date

Amedisys, Inc., announced that it will report results for the third quarter ended September 30, 2019, after the market closes on October 29, 2019.

October 16, 2019
·
1 min read
Policy

ImmunoCellular Therapeutics Announces Settlement of Derivative Action Lawsuit

The Court approved the settlement amount of one hundred forty-five thousand dollars ($145,000.00) to be paid by ImmunoCellular’s insurer to Plaintiff’s Counsel, and for a Service Award of one thousand dollars ($1,000.00) to be paid to Plaintiff from the Fee and Expense Award.

October 16, 2019
·
2 min read
Business

IQVIA to Announce Third-Quarter 2019 Results on October 30, 2019

The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

October 16, 2019
·
2 min read